These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2907820)

  • 41. Effect of xamoterol in a patient with idiopathic autonomic failure.
    Elizabeth J; Solomon LR; Lye M
    J Auton Nerv Syst; 1992 Apr; 38(1):65-8. PubMed ID: 1350286
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is xamoterol safe in chronic airflow obstruction?
    Roberts JA; Challenor VF; Waller DG
    Eur J Clin Pharmacol; 1992; 42(2):147-50. PubMed ID: 1352245
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Xamoterol in heart failure.
    von Olshausen K
    Lancet; 1988 May; 1(8595):1162. PubMed ID: 2896976
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of xamoterol, a beta 1 adrenoceptor partial agonist, in patients with ischaemic dysfunction of the left ventricle.
    Vigholt-Sørensen E; Faergeman O; Snow HM
    Br Heart J; 1989 Nov; 62(5):335-41. PubMed ID: 2574049
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Xamoterol monotherapy in heart failure. The European 'Corwin' Group.
    Timewell RM; Stark RD; Marlow HF
    Eur Heart J; 1990 Apr; 11 Suppl A():62-4. PubMed ID: 1971596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Beta-blocking and beta-stimulation in left ventricular failure].
    Waagstein F
    Lakartidningen; 1978 Nov; 75(47):4376-81. PubMed ID: 30870
    [No Abstract]   [Full Text] [Related]  

  • 47. Sympathetic modulation in practice: the German clinical experience.
    Kupper W; Erlemeier HH; Bleifeld W
    Eur Heart J; 1990 Apr; 11 Suppl A():19-25. PubMed ID: 1971586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Xamoterol in severe heart failure.
    Ikram H; Crozier IG
    Lancet; 1990 Aug; 336(8713):517-8. PubMed ID: 1975033
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparative effects of digoxin and xamoterol on arrhythmias in patients with mild to moderate heart failure.
    Klein W; Eber B; Rotman B
    Angiology; 1992 Apr; 43(4):281-6. PubMed ID: 1348403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of the chronic effects of oral xamoterol and enalapril on blood pressure and renal function in mild to moderate heart failure.
    Jamieson MJ; Webster J; Fowler G; Rawles J; Smith FW; Petrie JC
    Br J Clin Pharmacol; 1991 Mar; 31(3):305-12. PubMed ID: 1675867
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Illustration of the effects of long-term xamoterol therapy on the time course of left ventricular pressure.
    van Mechelen H; Ries A; Pouleur H; Rousseau MF
    Eur Heart J; 1990 Apr; 11 Suppl A():67-9. PubMed ID: 1971598
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Xamoterol, a beta 1-adrenoceptor partial agonist: review of the clinical efficacy in heart failure.
    Marlow HF
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):23S-30S. PubMed ID: 2572251
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effects of xamoterol in moderate cardiac insufficiency].
    Kayanakis JG; Larouchi L; Doat P; Grenet B; Fauvel JM; Bounhoure JP
    Presse Med; 1989 Apr; 18(13):667-70. PubMed ID: 2566161
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of xamoterol on sodium excretion in volunteers.
    Zech PY; Pozet N; Day MA; Snow HM; Madonna O; Hadj-Aissa A
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):89S-91S. PubMed ID: 2572266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative effects of xamoterol and digoxin in patients with mild to moderate heart failure. The Italian Xamoterol Multicenter Research Group.
    Eur Heart J; 1990 Apr; 11 Suppl A():50-1. PubMed ID: 1971591
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The electrophysiological effects of intravenous xamoterol in man.
    Bowes RJ; Gautam PC; Graham DR; Harley A
    Eur J Clin Pharmacol; 1986; 29(6):731-4. PubMed ID: 2872057
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Xamoterol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.
    Furlong R; Brogden RN
    Drugs; 1988 Oct; 36(4):455-74. PubMed ID: 2906865
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of age and renal impairment on the pharmacokinetics of xamoterol.
    Bastain W; Marlow HF
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):65S-66S. PubMed ID: 2572257
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of beta-adrenoceptor agents on the blood flow in carotid arteries in normal volunteers.
    Fitzgerald DE; Harry JD
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):73S-74S. PubMed ID: 2572260
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of xamoterol a new beta-adrenoceptor partial agonist, in patients with angina pectoris.
    Barrios L; Geboers J; Piessens JH; de Geest H
    Eur J Clin Pharmacol; 1986; 29(6):667-71. PubMed ID: 2872055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.